National Healthcare Expands Board With Two New Directors

An update from National Healthcare ( (NHC) ) is now available.

National HealthCare Corporation announced on February 17, 2026, that its Board of Directors unanimously expanded from seven to nine members effective February 12, 2026, appointing geriatrician and former AHCA/NCAL executive Dr. David Gifford and longtime NHC-affiliated operator and financial services executive Andrew Adams as independent directors. The move deepens the board’s expertise in geriatrics, public health, long-term care operations, and business expansion while reinforcing family continuity with the founding Adams family, with Gifford joining the Nominating and Corporate Governance Committee and Adams the Compensation Committee, potentially shaping NHC’s strategic direction in clinical quality and growth.

Dr. Gifford, a former Rhode Island health director and key figure in national long-term care quality and pandemic response, brings extensive experience at the intersection of geriatric medicine, policy, and healthcare operations that NHC expects will enhance its focus on elder care and clinical performance. Adams, who previously ran one of NHC’s largest continuing care retirement communities and later expanded a multistate financial services business, adds operational and growth-focused expertise alongside deep institutional knowledge as the grandson of the company’s founder and nephew of the current chairman, signaling an emphasis on both governance independence and continuity in the company’s leadership.

The most recent analyst rating on (NHC) stock is a Hold with a $161.00 price target. To see the full list of analyst forecasts on National Healthcare stock, see the NHC Stock Forecast page.

Spark’s Take on NHC Stock

According to Spark, TipRanks’ AI Analyst, NHC is a Outperform.

National Healthcare’s strong financial performance and positive technical indicators are the primary drivers of its stock score. The company’s stable financial foundation and growth potential are reinforced by its commitment to shareholder returns through dividends. However, the valuation is moderate, and the ongoing lease dispute introduces some risk, slightly impacting the overall score.

To see Spark’s full report on NHC stock, click here.

More about National Healthcare

National HealthCare Corporation is a leading U.S. provider of long-term care healthcare services, operating through affiliates 80 skilled nursing facilities with 10,329 beds, 26 assisted living communities, nine independent living communities, three behavioral health hospitals, 34 homecare agencies, and 33 hospice agencies. The company also offers Alzheimer’s and memory care, pharmacy and rehabilitation services, and management and accounting services to third-party post-acute operators, positioning it as a diversified player across the post-acute and senior-care continuum.

NHC’s broad footprint in skilled nursing, assisted and independent living, behavioral health, and home- and hospice-care reflects a strategic focus on aging and medically complex populations in the post-acute space. By integrating clinical services with operational and advisory capabilities, the company targets both owned and third-party facilities, aiming to capture value across multiple nodes of the long-term care ecosystem and strengthen its competitive standing in a fragmented market.

Average Trading Volume: 76,319

Technical Sentiment Signal: Buy

Current Market Cap: $2.63B

For an in-depth examination of NHC stock, go to TipRanks’ Overview page.